A new malaria study using a very large analysis of pooled individual patient data (IPD) from more than 70,000 patients of all ages, has been published today in BMC Medicine.

IDDO/WWARN and University of Cape Town (UCT) TDR post-doctoral fellow Dr Daniel Yilma presented his latest malaria research at the recent workshop in Ethiopia.

KINSHASA / NAIROBI / GENEVA – 28 February 2022 – The ANTICOV platform clinical trial, launched in September 2020 in 13 African countries to identify treatments for mild and moderate cases of COVID-19, has stopped recruiting patients into one of its treatment arms, the drug combination nitazoxanide a...

Early career researchers are invited to apply for the RSTMH 2022 grant programme to help fund a one-year project on any topic related to tropical medicine and global health.

KINSHASA / NAIROBI / GENEVA – 8 February 2022 – The ANTICOV platform clinical trial has started the recruitment of participants to test a new promising drug combination, fluoxetine and budesonide, as an early treatment for people affected with mild-to-moderate COVID-19.

WWARN experts recently spoke to Undark magazine about the emerging signs of antimalarial drug resistance in sub-Saharan Africa and what that means for the region.

A new study has highlighted the need for more rapid dissemination of molecular marker data to monitor artemisinin resistance.

Professor Paul Newton was announced new Distinguished International Fellow at the ASTMH Annual Meeting Awards Ceremony on the 17th November. This distinction formally recognises individuals who have made eminent contributions to a particular aspect of tropical medicine or hygiene.

A new, extensive systematic review has identified significant research gaps in the treatment of scrub typhus which could be improved by developing a database for individual participant data (IPD) to enable more detailed analyses to address important knowledge gaps such as the optimum dosing for chil...

IDDO has partnered with Vivli today, listing its COVID-19 studies on the platform to boost its reach across the global research community and increase both the speed of access and re-use of data.

A series of papers which reviewed portable devices to detect poor quality medicines has concluded major gaps in scientific evidence remain a key barrier for regulators to implement surveillance systems using such devices.

A new study suggests there are important but neglected issues with substandard and falsified (SF*) medicines and medical products used to prevent and treat cardiovascular diseases.

Two new Study Groups, a collaboration between IDDO and the global visceral leishmaniasis (VL) research community, have been formed to answer specific research questions about treatments. They will undertake individual patient data meta-analyses using datasets from multiple studies, across sub-popula...

A new, large-scale systematic review published today in PLOS Neglected Tropical Diseases has identified clear, significant research gaps in the diagnosis and treatment of Chagas disease.

Join the IDDO team who will be presenting at the 12th European Congress on Tropical Medicine and International Health (ECTMIH) between 28 September to 1 October. ECTMIH provides a platform for experts, scientists and researchers to present scientific developments and breakthroughs in tropical medici...

A new systematic review published today in PLOS Neglected Tropical Diseases has found that reports on the occurrence of Visceral Leishmaniasis (VL) in pregnant women are rare in published literature, are not systematically captured, and cases are rarely followed-up to detect the consequences of infe...

Preprints are increasingly being used to share manuscripts that are not yet peer-reviewed to enable the rapid dissemination of research findings. In particular, they have also become an important source of information for wider, non-specialist audiences keen to follow COVID-19 research developments,...

Substandard and falsified (SF*) medical products, including medicines, vaccines, diagnostic tests and medical devices are critical global public health issues and current SF surveillance in most of the world is extremely limited. Information sharing on SF incidents is very poor. Our Medicine Quality...

This year’s BSP Conference will run across two streams: the usual science stream with its mix of varied high quality themed scientific sessions, keynote speakers and presentations by postgraduate and postdoctoral researchers, and a second, specialist stream which will include a series of talks from ...

27 APRIL 2021 – The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test a new drug combination, nitazoxanide + ciclesonide, to treat people with mild-to-moderate COVID-19 before their cases become severe.